What Causes Lymph Nodes To Swell Under The Arm Medical Insights And Triggers

Published

Table of Contents

The axillary lymph nodes, strategically positioned beneath the arm, serve as critical sentinels in the immune system’s defense network. When these nodes swell—whether due to infection, inflammation, or systemic disorders—they often signal an underlying process requiring careful evaluation. Understanding the diverse etiologies, from bacterial invasions to autoimmune responses and occupational exposures, is essential for accurate diagnosis and timely intervention. This discussion explores the multifaceted causes of underarm lymphadenopathy, integrating clinical pathways, anatomical insights, and evidence-based preventive strategies.

Lymph node enlargement in the axillary region is rarely an isolated phenomenon; it frequently reflects broader physiological disruptions or localized triggers. Infectious agents such as Staphylococcus aureus or Epstein-Barr virus may provoke acute swelling, while chronic conditions like sarcoidosis or metastatic breast cancer introduce more insidious challenges. Environmental factors, including occupational hazards or allergic sensitivities, further complicate diagnostic clarity, necessitating a systematic approach to differentiate benign reactivity from malignant progression. By dissecting these mechanisms—through structured data tables, comparative analyses, and pathophysiological flowcharts—this examination equips clinicians and patients alike with a comprehensive framework for addressing underarm lymph node swelling.

what causes lymph nodes to swell under the arm

Medical Causes of Underarm Lymph Node Swelling

Underarm lymph node swelling, or axillary lymphadenopathy, arises from a spectrum of pathological processes ranging from acute infections to systemic malignancies. The axillary region drains the breast, upper limbs, and portions of the thoracic wall, making it particularly susceptible to localized and metastatic influences. Infectious agents, autoimmune responses, neoplastic transformations, and metabolic dysfunctions each contribute distinctively to lymph node enlargement, with clinical presentation and diagnostic approaches varying accordingly. Understanding these underlying mechanisms is critical for accurate differential diagnosis and targeted therapeutic intervention.

Infectious Causes of Localized Underarm Lymph Node Swelling

Infectious agents frequently trigger localized lymphadenopathy in the axillary region, particularly when primary infection sites—such as the skin, soft tissues, or adjacent structures—are involved. Bacterial, viral, and fungal pathogens exploit regional lymphatic drainage, leading to reactive hyperplasia or suppurative lymphadenitis. The following table summarizes key pathogens, their associated symptoms, typical clinical courses, and predisposing risk factors:
Pathogen Type Common Symptoms Typical Duration Risk Factors
Bacterial• Staphylococcus aureus (including MRSA)
• Streptococcus pyogenes• Mycobacterium tuberculosis (extrapulmonary)
  • Tender, erythematous, fluctuant lymph nodes
  • Fever, chills, localized pain (acute bacterial lymphadenitis)
  • Night sweats, weight loss (tuberculosis)
  • Overlying cellulitis or abscess formation
  • Acute: 7–14 days (resolves with antibiotics)
  • Chronic (TB): Months to years (persistent enlargement)
  • Recent skin trauma, folliculitis, or furunculosis
  • Immunocompromise (HIV, diabetes, chemotherapy)
  • Close contact with active TB cases
Viral• Epstein-Barr virus (EBV, infectious mononucleosis)
• Cytomegalovirus (CMV)
• Human herpesvirus 6 (HHV-6)
• HIV (primary infection)
  • Painless, bilateral axillary lymphadenopathy
  • Fever, pharyngitis, fatigue (EBV)
  • Hepatosplenomegaly (CMV)
  • Generalized lymphadenopathy with rash (HIV seroconversion)
  • Subacute: 2–4 weeks (self-limited)
  • Chronic (HIV): Persistent if untreated
  • Close contact with infected individuals
  • Young adulthood (EBV peak incidence)
  • Immunosuppression (CMV reactivation)
Fungal• Candida albicans (cutaneous dissemination)
• Sporothrix schenckii (sporotrichosis)
• Histoplasma capsulatum (disseminated)
  • Painless, firm nodes with overlying skin changes (e.g., intertrigo, ulcers)
  • Nodular lymphangitis (sporotrichosis)
  • Systemic symptoms (fever, cough) in disseminated histoplasmosis
  • Subacute to chronic: Weeks to months
  • Prolonged antibiotic use or immunosuppression (Candida)
  • Occupational exposure (gardening, soil contact)
  • Travel to endemic regions (Histoplasma)
Diagnostic Considerations:
  • Bacterial infections often present with acute pain and systemic inflammation, warranting empirical antibiotics (e.g., cephalexin for Staphylococcus; rifampin/isoniazid for TB).
  • Viral causes typically lack tenderness and resolve spontaneously, though EBV may require supportive care (e.g., corticosteroids for severe cases).
  • Fungal pathogens demand culture confirmation (e.g., KOH prep for Candida; biopsy for Sporothrix) due to treatment resistance (e.g., itraconazole, amphotericin B).

    • Non-Infectious Inflammatory and Autoimmune Conditions

    Autoimmune and granulomatous diseases frequently manifest as painless, persistent axillary lymphadenopathy due to chronic immune activation. Unlike infectious processes, these conditions often exhibit systemic symptoms, laboratory abnormalities, and a relapsing-remitting course. Key diagnostic markers include:

    - Sarcoidosis: Non-caseating granulomas in lymph nodes, elevated angiotensin-converting enzyme (ACE) levels, and bilateral hilar lymphadenopathy on chest imaging.

  • Systemic Lupus Erythematosus (SLE): Positive antinuclear antibodies (ANA), low complement levels (C3/C4), and extralymphatic manifestations (e.g., arthritis, malar rash).
  • Rheumatoid Arthritis (RA): Rheumatoid factor (RF) or anti-CCP antibodies, with lymphadenopathy often secondary to methotrexate or disease activity.

    • Pathophysiological Differences from Infections:

    Autoimmune lymphadenopathy arises from polyclonal B-cell activation and follicular hyperplasia, whereas infections trigger monoclonal or oligoclonal responses localized to the draining area. Unlike bacterial/viral causes, autoimmune swelling is typically non-tender, bilateral, and associated with serological markers rather than acute-phase reactants (e.g., CRP, procalcitonin).
    Clinical Features by Condition:
    Condition Lymph Node Characteristics Systemic Features Key Lab Findings
    Sarcoidosis Firm, rubbery, mobile; may coalesce Dry cough, erythema nodosum, uveitis ↑ ACE, ↑ CD4/CD8 ratio in BAL, hypercalcemia
    Systemic Lupus Erythematosus (SLE) Discrete, non-tender; often generalized Malar rash, photosensitivity, glomerulonephritis +ANA, +anti-dsDNA, ↓C3/C4, thrombocytopenia
    Rheumatoid Arthritis (RA) Lymphadenopathy rare; if present, cervical/axillary Symmetrical arthritis, morning stiffness +RF, +anti-CCP, ↑ ESR/CRP
    Diagnostic Workup:
  • Imaging: Chest CT (sarcoidosis), ultrasound (guided biopsy for granulomas).
  • Biopsy: Non-caseating granulomas confirm sarcoidosis; lymphoid tissue architecture in SLE/RA shows germinal center hyperplasia.
  • Therapy: Corticosteroids (first-line for sarcoidosis), hydroxychloroquine (SLE), or DMARDs (RA).
    • Malignant lymphadenopathy in the axilla necessitates urgent evaluation, as it may reflect primary hematologic malignancies or metastatic spread from adjacent structures. Lymphomas (Hodgkin’s and non-Hodgkin’s) and breast

    what causes lymph nodes to swell under the arm - Ilustrasi 2

    Environmental and Lifestyle Triggers of Underarm Lymph Node Swelling

    Environmental exposures and lifestyle behaviors significantly influence lymphatic reactivity, particularly in axillary (underarm) lymph nodes. Occupational hazards, allergic sensitivities, mechanical trauma, and systemic immune dysregulation collectively contribute to localized lymphadenopathy. Understanding these triggers enables targeted preventive strategies and early intervention to mitigate chronic inflammation or infection risks.

    The lymphatic system acts as a surveillance network, filtering pathogens, toxins, and cellular debris. Disruptions—whether chemical, immunological, or physical—compromise its efficiency, leading to compensatory swelling as nodes attempt to process increased antigenic load. Below, occupational hazards, allergic mechanisms, trauma-induced inflammation, and lifestyle-related immune suppression are examined with mechanistic insights and clinical applications.

    Occupational Hazards and Lymphatic Disruption

    Prolonged exposure to industrial chemicals, radiation, or biological agents in occupational settings impairs lymphatic drainage and node function. These agents either directly damage lymphatic endothelial cells or induce systemic immune activation, triggering axillary lymphadenopathy. Occupational health guidelines emphasize risk stratification based on exposure duration and concentration thresholds.

    Key occupational triggers and their mechanisms:

    1. Solvents and Volatile Organic Compounds (VOCs)

  • Mechanism:
  • Direct cytotoxicity: Solvents (e.g., benzene, toluene, trichloroethylene) disrupt lymphatic endothelial tight junctions via oxidative stress, increasing vascular permeability and edema.
  • Immune dysregulation: VOCs induce Th2 skew, elevating IgE and mast cell degranulation, which exacerbates localized inflammation.
  • Lymphatic stasis: Chronic exposure reduces lymphatic contractility due to smooth muscle relaxation (via nitric oxide overproduction).
  • Preventive Measures:
  • Mandatory use of air-purifying respirators (APRs) with activated carbon filters for high-exposure tasks.
  • Skin barriers (e.g., nitrile gloves, protective creams with dimethicone) to prevent dermal absorption.
  • Biological monitoring (e.g., urinary metabolites like t,t-muconic acid for benzene) to track subclinical exposure.
  • Rotational work schedules to limit cumulative dose.

    • 2. Ionizing Radiation (e.g., Medical Imaging, Nuclear Work)

  • Mechanism:
  • DNA damage in lymphatic endothelial cells (LECs): Radiation induces p53-dependent apoptosis, reducing lymphatic vessel density and impairing drainage.
  • Fibrosis: Chronic low-dose exposure triggers transforming growth factor-β (TGF-β) upregulation, leading to lymphangiogenesis failure.
  • Secondary infections: Radiation weakens Langerhans cell surveillance in axillary skin, increasing susceptibility to Staphylococcus aureus or fungal colonization.
  • Preventive Measures:
  • Dosimetry badges and lead shielding for workers in radiology or nuclear facilities.
  • Prophylactic antibiotics (e.g., cephalexin) for high-risk individuals post-exposure.
  • Regular dermatological exams to detect early radiation dermatitis in axillary folds.

    • 3. Biological Agents (e.g., Mycobacteria, Fungi, Viruses)

  • Mechanism:
  • Granulomatous inflammation: Mycobacterium avium-intracellulare (MAI) or Histoplasma capsulatum trigger Th1-mediated giant cell formation in axillary nodes, mimicking tuberculosis.
  • Viral latency: Human herpesvirus-8 (HHV-8) in immunocompromised workers (e.g., lab technicians) may reactivate, causing Kaposi’s sarcoma-associated lymphadenopathy.
  • Delayed hypersensitivity: Occupational exposure to beryllium (e.g., aerospace manufacturing) induces sarcoid-like granulomas via CD4+ T-cell activation.
  • Preventive Measures:
  • Vaccination (e.g., BCG for high-risk mycobacterial exposure).
  • HEPA filtration in labs handling biohazards.
  • Serological screening (e.g., BeLPT for beryllium sensitization).
  • Post-exposure prophylaxis (e.g., itraconazole for Histoplasma).

    • 4. Heavy Metals (e.g., Nickel, Chromium, Arsenic)

  • Mechanism:
  • Nickel: Binds major histocompatibility complex (MHC) class II, triggering CD4+ T-cell activation and contact dermatitis with secondary lymphadenopathy.
  • Chromium (Cr VI): Generates reactive oxygen species (ROS), damaging lymphatic valves and causing lymphedema.
  • Arsenic: Inhibits lysosomal function in macrophages, impairing antigen presentation and node enlargement.
  • Preventive Measures:
  • Engineering controls (e.g., wet sanding for chromium-plating workers).
  • Chelation therapy (e.g., succimer for arsenic) in acute poisoning cases.
  • Patch testing for nickel hypersensitivity in at-risk populations (e.g., jewelry workers).

    • Allergic Reactions and Localized Lymphadenopathy

    Allergic responses in the axillary region often manifest as asymmetric lymph node enlargement due to proximity to common allergen entry points (e.g., skin, respiratory tract). These reactions range from immediate IgE-mediated to delayed cell-mediated hypersensitivity, with cross-reactivity between sensitizers (e.g., nickel and fragrances). Understanding the temporal and immunological distinctions aids in differential diagnosis and allergen avoidance.

    Manifestations of allergic axillary lymphadenopathy:

  • Acute swelling: Occurs within minutes to hours post-exposure, resolving in 24–72 hours (e.g., insect bites, cosmetic reactions).
  • Chronic enlargement: Persists for weeks to months, often with rubbery consistency (e.g., nickel dermatitis, poison ivy).
  • Regional distribution: Nodes drain specific areas (e.g., central axillary nodes for upper arm allergens, lateral nodes for breast/shoulder contact).

    • Comparison of Immediate vs. Delayed Hypersensitivity Reactions:

    FeatureImmediate (IgE-Mediated)Delayed (Cell-Mediated)
    MechanismMast cell degranulation via FcεRI-IgE cross-linkingCD4+ Th1/Th17 activation (48–72 hours)
    Key MediatorsHistamine, leukotrienes, prostaglandin D2IFN-γ, TNF-α, IL-17, macrophage recruitment
    Onset5–30 minutes post-exposure24–72 hours
    Resolution TimeHours to daysDays to weeks
    Common AllergensInsect venoms, latex, fragrances (limonene, linalool)Nickel, poison ivy (urushiol), neomycin, epoxy resins
    Skin FindingsUrticaria, angioedemaEczematous plaques, vesicles, lichenification
    Lymph Node CharacteristicsTender, fluctuant, bilateral (if systemic)Firm, unilateral, non-tender
    Diagnostic ToolsSkin prick test (SPT), serum IgEPatch testing, lymph node biopsy (granulomas)
    TreatmentAntihistamines (H1 blockers), epinephrine (severe)Topical corticosteroids, systemic steroids (e.g., prednisone)
    Cross-Reactive Allergens in Axillary Lymphadenopathy:
  • Nickel: Found in jewelry, belts, denim buttons, and deodorant cans; cross-reacts with cobalt and chromium.
  • Fragrances: Linalool (lavender), limonene (citrus), and eugenol (clove) in perfumes and detergents often trigger allergic contact dermatitis with axillary node involvement.
  • Preservatives: Formaldehyde-releasing agents (e.g., in antiperspirants) and quaternium-15 cause delayed reactions in sensitive individuals.
  • Insect Bites: Salivary proteins (e.g., Ves v 1 in wasps, Api m 1 in bees) induce IgE-mediated reactions with rapid node swelling.

    • Clinical Pearl:
    > *"Axillary lymphadenopathy from allergies typically presents with asymmetry and localized erythema at the allergen’s point of contact. Patch testing should include standard series + personal products (e.g., cosmetics, detergents) to identify hidden sensitizers. Oral antihistamines (e.g

    what causes lymph nodes to swell under the arm - Ilustrasi 3

    Anatomical and Physiological Foundations of Underarm Lymph Node Swelling

    The axillary (underarm) lymph nodes serve as critical sentinels in the lymphatic drainage of the upper body, integrating anatomical connections with immune surveillance. Their strategic location between the breast, chest wall, and upper limbs necessitates a precise understanding of lymphatic pathways, node architecture, and functional responses to pathological stimuli. Swelling in these nodes—whether localized or diffuse—reflects underlying physiological or pathological processes, ranging from reactive immune activation to neoplastic infiltration. Below, the lymphatic drainage networks, node-specific anatomy, immune defense mechanisms, and laterality-based patterns are examined to elucidate the mechanistic basis of axillary lymphadenopathy.

    Lymphatic Drainage Pathways of the Axillary Region

    The axillary lymph nodes receive lymphatic drainage from four primary anatomical regions: the breast, upper limb, chest wall, and upper abdominal wall. These pathways converge into five main groups of axillary nodes, each with distinct efferent connections to the central lymphatic system. Below is a descriptive representation of key nodes and vessels:

    [Central Axillary Nodes] ← [Pectoral (Anterior) Nodes] ← Breast (medial quadrants, nipple-areolar complex)
    ↑
    [Lateral (Humeral) Nodes] ← Upper Limb (forearm, hand, arm)
    ↑
    [Subscapular (Posterior) Nodes] ← Chest Wall (lateral thoracic region, scapular area)
    ↑
    [Apical Nodes] → Subclavian Trunk → Right Lymphatic Duct (right side) / Thoracic Duct (left side)

    Key Connections:

  • Breast Drainage: ~75% of lymphatic drainage from the breast flows to the pectoral (anterior) nodes, with additional routes to the central and apical nodes. The nipple-areolar complex drains bilaterally, explaining why breast cancer may present with contralateral axillary involvement in advanced stages.
  • Upper Limb Drainage: Superficial and deep lymphatics of the arm drain sequentially through lateral (humeral) nodes before reaching the central and apical nodes.
  • Chest Wall Drainage: The subscapular (posterior) nodes collect lymph from the scapular region and lateral thoracic wall, merging with the central axillary chain.
  • Upper Abdominal Drainage: Lymph from the lower intercostal spaces and upper abdominal wall may drain into the infraclavicular nodes, bypassing the axilla entirely in some cases.

    • Clinical Relevance:
    Disruption in these pathways—such as ligament of Cooper obstruction (in breast cancer) or surgical lymphadenectomy—can alter drainage patterns, leading to collateral lymphatic mapping and secondary swelling in adjacent nodes (e.g., supraclavicular or cervical nodes).

    Lymph Node Anatomy and Swelling Patterns

    The structural organization of lymph nodes dictates their response to pathological stimuli, influencing whether swelling presents as discrete enlargement (single node) or matting (confluent, rubbery masses). Below are the anatomical distinctions and their implications:

    Node Architecture:

  • Cortex: Outer region containing B-cell follicles (germinal centers) and subcapsular sinuses, where antigen presentation and antibody production occur.
  • Paracortex: Middle region rich in T-cells and high endothelial venules (HEVs), critical for cell-mediated immunity.
  • Medulla: Inner region with medullary cords (macrophages, plasma cells) and medullary sinuses, facilitating lymph flow.

    • Vascular Supply:

  • Afferent Vessels: Multiple lymphatic channels entering the hilum-free convex surface, carrying antigens and cells.
  • Efferent Vessels: Single or few vessels exiting the hilum, regulating lymph outflow and pressure.

    • Swelling Patterns and Pathophysiology:
    The distinction between reactive hyperplasia and malignant infiltration is rooted in microscopic architecture and clinical presentation:

    "Reactive hyperplasia" involves expanded germinal centers with polymorphic lymphocytes, follicular dendritic cell networks, and preserved node architecture. Malignant infiltration, conversely, disrupts normal histology with monoclonal B/T cells, fibrosis, or extracapsular spread.
    FeatureReactive HyperplasiaMalignant Infiltration
    Node Size1–2 cm, discrete>2 cm, firm/rock-hard, fixed to tissue
    ConsistencySoft, mobile, tenderHard, rubbery, or stony; skin tethering
    Microscopic ChangesGerminal center expansion, increased macrophagesEffacement of follicles, atypical lymphocytes, necrosis
    Associated SymptomsFever, fatigue, viral prodromePainless, progressive, night sweats, weight loss
    Lymphatic FlowPreserved efferent drainageObstruction → upstream congestion (e.g., arm swelling)
    Matting vs. Discrete Enlargement:
  • Discrete Nodes: Typically indicate localized infection (e.g., cellulitis, mastitis) or early malignancy (e.g., ductal carcinoma in situ).
  • Matted Nodes: Suggest chronic inflammation (e.g., tuberculosis lymphadenitis) or advanced malignancy (e.g., inflammatory breast cancer with dermal lymphatic invasion).

    • Role of Lymphatics in Immune Defense and Response Mechanisms

    The axillary lymph nodes act as biological filters, capturing antigens from the upper body and initiating adaptive immune responses. Below is a step-by-step breakdown of the immune cascade triggered by lymphatic drainage:
    1. Antigen Capture and Transport:
      Dendritic cells in peripheral tissues (e.g., skin, breast parenchyma) phagocytose pathogens or tumor antigens. These cells migrate via afferent lymphatics to the paracortex, where they present antigens to naive T-cells via MHC class II molecules.
    2. T-Cell Activation and Proliferation:
      Naive CD4+ T-cells differentiate into Th1/Th2 cells (cytokine-dependent) or Tfh cells (follicular helper T-cells) under the influence of IL-12 (Th1) or IL-4 (Th2). CD8+ T-cells undergo cytotoxic differentiation (perforin/granzyme release) if stimulated by cross-presenting dendritic cells.
    3. B-Cell Response and Antibody Production:
      Activated Tfh cells interact with B-cells in germinal centers, inducing class switching (IgM → IgG/IgA) and somatic hypermutation to produce high-affinity antibodies. Plasma cells migrate to the medullary cords for antibody secretion into lymph.
    4. Efferent Lymphatic Spread:
      Activated lymphocytes and antibodies exit via efferent vessels, entering systemic circulation to target the primary infection site. Memory cells persist in the node for rapid recall responses.
    5. Resolution or Chronicity:
    6. Acute Infection: Lymph nodes return to baseline size post-resolution (e.g., after viral lymphadenitis).
    7. Chronic Infection: Persistent antigen exposure leads to follicular hyperplasia (e.g., HIV-associated lymphadenopathy).
    8. Malignancy: Neoplastic cells evade immune surveillance via PD-L1 upregulation or T-cell exhaustion, leading to unchecked proliferation.
    Clinical Correlates:
  • Delayed-Type Hypersensitivity (DTH): Axillary nodes may enlarge in contact dermatitis (e.g., poison ivy) due to Th1-mediated delayed responses.
  • Autoimmune Disorders: Sjögren’s syndrome or rheumatoid arthritis can cause painful, bilateral axillary lymphadenopathy via lymphocytic infiltration.
  • Post-Vaccination: Influenza or HPV vaccines may induce localized axillary swelling due to adjuvant-driven immune activation.

    • Laterality-Based Patterns in Axillary Lymphadenopathy

    The laterality of lymph node swelling provides critical diagnostic clues, differentiating benign self-limited processes from malignant or systemic pathologies. Below is a comparative analysis:
    Laterality Common Causes Red Flags Recommended Workup
    Unilateral